Aggressive course of disease in dementia

@article{Gauthier2006AggressiveCO,
  title={Aggressive course of disease in dementia},
  author={Serge Gauthier and Bruno Vellas and Martin R. Farlow and David Burn},
  journal={Alzheimer's \& Dementia},
  year={2006},
  volume={2},
  pages={210-217}
}
The rate of disease progression in Alzheimer's disease (AD) patients is variable. A significant proportion of AD patients appear to experience an aggressive course of disease, and this has a major impact on prognosis, the patients, and their caregivers and society in general. Here we review the current literature on an aggressive course of disease in dementia and how it can be recognized in clinical practice. We also discuss the options available for treating patients with this condition. 
Current and future therapies for Alzheimer's disease and related disorders
TLDR
It is possible that a similar approach will be useful in vascular dementia, mixed Alzheimer’s disease/vascular disease, Parkinson's disease dementia, dementia with Lewy bodies and fronto–temporal dementia.
Biochemical and Radiological Markers of Alzheimer's Disease Progression.
TLDR
This review summarizes the results of studies on potential biochemical and radiological markers related to AD progression and indicates that there is a lack of a reliable biomarker that enables one to stratify the risk of deterioration.
Movement Disorders in Alzheimer’s Disease
TLDR
This chapter reviews mainly those movement disorders resulting from the neurodegenerative process, and psychiatric complications of AD either itself or due to the use of neuroleptics represent another source of motor symptoms.
Predicting cognitive decline in Alzheimer's disease: An integrated analysis
TLDR
The ability of pharmacological treatment to attenuate the risk of rapid cognitive decline in patients with Alzheimer's disease remains undefined.
Neuropsychiatric Symptoms in Alzheimer’s Disease Patients: Improving the Diagnosis
Neuropsychiatric symptoms have been strongly related to higher risk of cognitive decline, elevated clinical deterioration, increased morbidity and mortality, heavy caregiver burden, and early
Apathy in Alzheimer’s disease: Contribution to a clinical view on progression of dementia
TLDR
Apathy is a distinct syndrome among patients with AD and increases with global deterioration, reinforcing the hypothesis that apathy severity aggravates as the disease progresses.
RAPID progression: tool for screening aggressive course of disease (ACD) in Alzheimer dementia.
TLDR
The present pilot study suggests that the Thai RAPID can be a valuable tool for the ACD screening and for progression assessment in AD patients.
Diagnosis of Alzheimer’s disease patients with rapid cognitive decline in clinical practice: Interest of the Deco questionnaire
TLDR
The Deco test appears to be a simple tool to alert the physician to the possibility of an aggressive course of the disease which warrants particular management and is validated as a diagnostic tool for rapid decline.
Markers of Prognosis in Neurodegenerative Dementia
Background: A prognostic marker should provide information about course and outcome of disease, e.g. predict time to a given endpoint or rate of progression due to disease in patients or subgroups
Functional dependence and caregiver burden in Alzheimer's disease: a controlled trial on the benefits of motor intervention
TLDR
The aim of this study was to verify if a 6‐month motor intervention programme promoted functionality in Alzheimer's patients and attenuated caregivers' burden.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
TLDR
This study demonstrates that LBV is characterized by a faster cognitive decline and accelerated mortality compared with AD.
Predictors of Decline in Alzheimer's Disease
TLDR
The results of this study do not support age of onset as a predictor of the course of AD, but poor performance on language tests does predict a more rapid rate of decline in AD.
Distinction Between Preclinical Alzheimer's Disease and Depression
OBJECTIVE: To assess the prevalence of depression in subjects with preclinical Alzheimer's disease (AD) and to investigate the possibility of differentiating subjects with preclinical AD and
Cognitive deterioration in Alzheimer’s disease: is the early course predictive of the later stages?
TLDR
It is suggested that, in future clinical trials on Alzheimer's disease, a stratification of participants based on the early rate of cognitive deterioration may be considered, and a tool is provided for predicting the speed of cognitive decline of patients from a single MODA assessment.
A method for estimating progression rates in Alzheimer disease.
TLDR
An easily calculable rate of early disease progression can classify patients as rapid, intermediate, or slow progressors with good predictive value, even at initial presentation.
Rate of cognitive decline and mortality in Alzheimer’s disease
TLDR
Mortality in AD is strongly associated with rate of cognitive decline, and risk of death was increased more than threefold in the subgroup with mild decline, more than fivefold in those with moderately rapid decline,and more than eightfold inThose with the most rapid decline.
Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease
TLDR
It is suggested that for both LBV and AD, earlier age at onset may predict a more aggressive disease course.
Cognitive Decline in Patients with Alzheimer Disease: Differences in Patients with and without Extrapyramidal Signs
TLDR
Overall, patients with EPS deteriorated 67% faster on MMSE than did patients with no evidence of EPS, indicating that the clinical presence of EPS is a poor overall prognostic sign in patients with a clinical diagnosis of AD.
Rapid cognitive decline: searching for a definition and predictive factors among elderly with Alzheimer's disease.
TLDR
The main objective of this review was to elaborate a proposal of definition of rapid cognitive decline in order to facilitate its applicability into ordinary medical practice and to be relevant for clinical-decision making in old patients with AD.
Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease
Apathy is defined as a lack of motivation in behavior, cognition and affect. This syndrome is frequent in various neuropsychiatric diseases but little is known about its pathophysiology.
...
1
2
3
4
5
...